T1	p 63 125	asthma due to house dust mite Dermatophagoides pteronyssinus :
T2	p 295 318	house dust mite ( HDM )
T3	p 387 421	10 patients with asthma due to HDM
T4	p 458 466	patients
T5	i 6 69	Local immunotherapy by inhalation of a powder extract in asthma
T6	i 93 123	Dermatophagoides pteronyssinus
T7	i 157 183	parenteral immunotherapy .
T8	i 231 320	local immunotherapy ( LI ) by inhalation of a powder extract of house dust mite ( HDM ) ,
T9	i 335 389	with parenteral immunotherapy ( PI ) by injection , 10
T10	i 404 410	asthma
T11	i 489 534	LI and subcutaneous injections of placebo , 5
T12	i 566 600	PI and inhalation of lactose for 6
T13	i 676 697	disodium cromoglycate
T14	i 1079 1094	distilled water
T15	o 215 227	tolerability
T16	o 756 826	symptoms score and in peak expiratory flow ( PEF ) -derived parameters
T17	o 902 942	late component of the bronchial response
T18	o 1218 1245	important adverse reactions
T19	o 1287 1299	side effects